Copyright Reports & Markets. All rights reserved.

Global and China Cancer Genome Sequencing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Second generation
    • 1.2.3 Third generation
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Genome Sequencing Market Share by Application: 2020 VS 2026
    • 1.3.2 Treatment
    • 1.3.3 Research
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Genome Sequencing Market Perspective (2015-2026)
  • 2.2 Global Cancer Genome Sequencing Growth Trends by Regions
    • 2.2.1 Cancer Genome Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer Genome Sequencing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer Genome Sequencing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Genome Sequencing Players by Market Size
    • 3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
  • 3.4 Global Cancer Genome Sequencing Market Concentration Ratio
    • 3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2019
  • 3.5 Key Players Cancer Genome Sequencing Area Served
  • 3.6 Key Players Cancer Genome Sequencing Product Solution and Service
  • 3.7 Date of Enter into Cancer Genome Sequencing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genome Sequencing Breakdown Data by Type (2015-2026)

  • 4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2021-2026)

5 Cancer Genome Sequencing Breakdown Data by Application (2015-2026)

  • 5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2015-2020)
  • 5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Genome Sequencing Market Size (2015-2026)
  • 6.2 North America Cancer Genome Sequencing Market Size by Type (2015-2020)
  • 6.3 North America Cancer Genome Sequencing Market Size by Application (2015-2020)
  • 6.4 North America Cancer Genome Sequencing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Cancer Genome Sequencing Market Size (2015-2026)
  • 7.2 Europe Cancer Genome Sequencing Market Size by Type (2015-2020)
  • 7.3 Europe Cancer Genome Sequencing Market Size by Application (2015-2020)
  • 7.4 Europe Cancer Genome Sequencing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Cancer Genome Sequencing Market Size (2015-2026)
  • 8.2 China Cancer Genome Sequencing Market Size by Type (2015-2020)
  • 8.3 China Cancer Genome Sequencing Market Size by Application (2015-2020)
  • 8.4 China Cancer Genome Sequencing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Cancer Genome Sequencing Market Size (2015-2026)
  • 9.2 Japan Cancer Genome Sequencing Market Size by Type (2015-2020)
  • 9.3 Japan Cancer Genome Sequencing Market Size by Application (2015-2020)
  • 9.4 Japan Cancer Genome Sequencing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Cancer Genome Sequencing Market Size (2015-2026)
  • 10.2 Southeast Asia Cancer Genome Sequencing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Cancer Genome Sequencing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Cancer Genome Sequencing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Agilent Technologies
    • 11.1.1 Agilent Technologies Company Details
    • 11.1.2 Agilent Technologies Business Overview
    • 11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
    • 11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2015-2020))
    • 11.1.5 Agilent Technologies Recent Development
  • 11.2 GE Healthcare Life Sciences
    • 11.2.1 GE Healthcare Life Sciences Company Details
    • 11.2.2 GE Healthcare Life Sciences Business Overview
    • 11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
    • 11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.2.5 GE Healthcare Life Sciences Recent Development
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Company Details
    • 11.3.2 Johnson & Johnson Business Overview
    • 11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
    • 11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.3.5 Johnson & Johnson Recent Development
  • 11.4 LI-COR Biosciences
    • 11.4.1 LI-COR Biosciences Company Details
    • 11.4.2 LI-COR Biosciences Business Overview
    • 11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
    • 11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.4.5 LI-COR Biosciences Recent Development
  • 11.5 Abbott Laboratories
    • 11.5.1 Abbott Laboratories Company Details
    • 11.5.2 Abbott Laboratories Business Overview
    • 11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
    • 11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.5.5 Abbott Laboratories Recent Development
  • 11.6 Beckman Coulter
    • 11.6.1 Beckman Coulter Company Details
    • 11.6.2 Beckman Coulter Business Overview
    • 11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
    • 11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.6.5 Beckman Coulter Recent Development
  • 11.7 Bayer
    • 11.7.1 Bayer Company Details
    • 11.7.2 Bayer Business Overview
    • 11.7.3 Bayer Cancer Genome Sequencing Introduction
    • 11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.7.5 Bayer Recent Development
  • 11.8 Hamilton Thorne Biosciences
    • 11.8.1 Hamilton Thorne Biosciences Company Details
    • 11.8.2 Hamilton Thorne Biosciences Business Overview
    • 11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
    • 11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.8.5 Hamilton Thorne Biosciences Recent Development
  • 11.9 Integrated DNA Technologies
    • 11.9.1 Integrated DNA Technologies Company Details
    • 11.9.2 Integrated DNA Technologies Business Overview
    • 11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
    • 11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.9.5 Integrated DNA Technologies Recent Development
  • 11.10 Microchip Biotechnologies
    • 11.10.1 Microchip Biotechnologies Company Details
    • 11.10.2 Microchip Biotechnologies Business Overview
    • 11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
    • 11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 11.10.5 Microchip Biotechnologies Recent Development
  • 11.11 Myriad Genetics
    • 10.11.1 Myriad Genetics Company Details
    • 10.11.2 Myriad Genetics Business Overview
    • 10.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
    • 10.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 10.11.5 Myriad Genetics Recent Development
  • 11.12 Commonwealth Biotechnologies
    • 10.12.1 Commonwealth Biotechnologies Company Details
    • 10.12.2 Commonwealth Biotechnologies Business Overview
    • 10.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
    • 10.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 10.12.5 Commonwealth Biotechnologies Recent Development
  • 11.13 ZS Genetics
    • 10.13.1 ZS Genetics Company Details
    • 10.13.2 ZS Genetics Business Overview
    • 10.13.3 ZS Genetics Cancer Genome Sequencing Introduction
    • 10.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 10.13.5 ZS Genetics Recent Development
  • 11.14 Pacific Biosciences
    • 10.14.1 Pacific Biosciences Company Details
    • 10.14.2 Pacific Biosciences Business Overview
    • 10.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
    • 10.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
    • 10.14.5 Pacific Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cancer Genome Sequencing Scope and Market Size
    Cancer Genome Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Genome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Second generation
    Third generation

    Market segment by Application, split into
    Treatment
    Research

    Based on regional and country-level analysis, the Cancer Genome Sequencing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Genome Sequencing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Agilent Technologies
    GE Healthcare Life Sciences
    Johnson & Johnson
    LI-COR Biosciences
    Abbott Laboratories
    Beckman Coulter
    Bayer
    Hamilton Thorne Biosciences
    Integrated DNA Technologies
    Microchip Biotechnologies
    Myriad Genetics
    Commonwealth Biotechnologies
    ZS Genetics
    Pacific Biosciences

    Buy now